Merck KGaA (FRA:MRK)

Germany flag Germany · Delayed Price · Currency is EUR
119.80
-2.40 (-1.96%)
Last updated: Apr 28, 2025
-22.38%
Market Cap 52.67B
Revenue (ttm) 21.16B
Net Income (ttm) 2.78B
Shares Out n/a
EPS (ttm) 6.39
PE Ratio 18.97
Forward PE n/a
Dividend 2.20 (1.80%)
Ex-Dividend Date Apr 28, 2025
Volume n/a
Average Volume 645
Open 119.80
Previous Close 122.20
Day's Range 119.80 - 119.80
52-Week Range 108.00 - 176.50
Beta n/a
RSI 48.54
Earnings Date May 15, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a... [Read more]

Industry Pharmaceutical Preparations
Founded 1668
Employees 59,020
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial Statements

News

EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition

EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition 24-Apr-2025 / 22:45 CET/CEST Disclosure of...

3 days ago - Wallstreet:Online

Germany's Merck nears roughly $3.5 billion deal for SpringWorks, WSJ reports

Germany's Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics , the Wall Street Journal reported on Thursday, citing people familiar with the matter.

3 days ago - Reuters

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks

The two companies have been talking for months about a deal

3 days ago - WSJ

Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally to Bring STEM Education to Students

Curiosity Cube tours North America, Europe, and for the first time, Africa Mobile science lab aims to reach 60,000 students in 19 countries Interactive lessons on artificial intelligence designed to s...

3 days ago - Financial Post

Zebra Technologies and Merck KGaA, Darmstadt, Germany Collaborate to Create Safety and Traceability Solutions

Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitising and automating frontline workflows, and Merck KGaA, Darmstadt, Germany, a leading science and technology company, today ann...

4 weeks ago - Wallstreet:Online

EQS-DD: Merck KGaA: Freifrau Helene von Roeder, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 16:24 CET/CEST The issuer is solely responsi...

4 weeks ago - Wallstreet:Online

EQS-DD: Merck KGaA: Peter Guenter, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 16:16 CET/CEST The issuer is solely responsi...

4 weeks ago - Wallstreet:Online

EQS-DD: Merck KGaA: Dr. Matthias Heinzel, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 16:09 CET/CEST The issuer is solely responsi...

4 weeks ago - Wallstreet:Online

EQS-DD: Merck KGaA: Belén Garijo Lopez, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 15:59 CET/CEST The issuer is solely responsi...

4 weeks ago - Wallstreet:Online

Merck KGaA: Still A Bit Too Expensive

Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free cash flow yield. Read why MKGAF is a hold.

5 weeks ago - Seeking Alpha

Merck KGaA (MKGAF) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

Merck KGaA (MKGAF) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic Investments Propel Performance

7 weeks ago - GuruFocus

Resilience is part of our DNA, says Merck KGaA CEO

Belén Garijo, CEO of Merck KGaA, said the German pharmaceutical company has increased its readiness to deal with the ongoing geopolitical uncertainty, and is confident it will continue delivering prof...

7 weeks ago - CNBC International TV

Resilience is part of our DNA, says Merck KGaA CEO

Beln Garijo, CEO of Merck KGaA, said the German pharmaceutical company has increased its readiness to deal with the ongoing geopolitical uncertainty, and is confident it will continue delivering profi...

7 weeks ago - CNBC

Merck KGaA Sees Profit Growth in 2025 as Recovery Takes Hold

Merck KGaA forecast rising profit this year as its life science business continues to recover and the boom in AI lifts demand at its semiconductor division.

7 weeks ago - Financial Post

Merck KGaA Non-GAAP EPS of €8.63, revenue of €21.16B; initiates FY25 outlook

Merck KGaA press release (MKGAF): FY Non-GAAP EPS of €8.63. Revenue of €21.16B (+0.8% Y/Y) (organically: +2.0%). EBITDA pre rose to € 6.1 billion (organically: +6.9%). Stable dividend

7 weeks ago - Seeking Alpha

Merck KGaA sees forex-adjusted earnings growth of up to 8% this year

Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production.

7 weeks ago - Reuters

Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors

Wiley (NYSE: WLY), one of the world’s largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...

7 weeks ago - Wallstreet:Online

Merck KGaA to replace two executives with company veterans

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it added that its strategy remains unchanged.

2 months ago - Reuters

Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics

Merck KGaA is in advanced talks to ... Full story available on Benzinga.com

2 months ago - Benzinga

Crude Oil Rises Sharply; Manhattan Associates Shares Slide

U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 150 points on Monday. The Dow traded up 0.40% to 44,482.54 while the NASDAQ gained 1.16% to 19,750.22. T...

2 months ago - Benzinga

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition

EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition 10-Feb-2025 / 20:06 CET/CEST Disclosure of an in...

2 months ago - Wallstreet:Online

Rockwell Automation Posts Upbeat Earnings, Joins Insperity, BP, Alibaba And Other Big Stocks Moving Higher On Monday

U.S. stocks were higher, with the Nasdaq Composite gaining around 200 points on Monday. Shares of Rockwell Automation, Inc. (NYSE: ROK) rose sharply during Monday's session after the company reported...

2 months ago - Benzinga